Glycyl-L-Prolyl-L-Glutamate Pseudotripeptides for Treatment of Alzheimer’s Disease

So far, there is no effective disease-modifying therapies for Alzheimer’s Disease (AD) in clinical practice. In this context, glycine-L-proline-L-glutamate (GPE) and its analogs may open the way for developing a novel molecule for treating neurodegenerative disorders, including AD. In turn, this stu...

全面介紹

Na minha lista:
書目詳細資料
發表在:Biomolecules
Main Authors: Turkez, Hasan, Cacciatore, Ivana, Marinelli, Lisa, Fornasari, Erika, Aslan, Mehmet Enes, Cadirci, Kenan, Kahraman, Cigdem Yuce, Caglar, Ozge, Tatar, Abdulgani, Di Biase, Giuseppe, Hacimuftuoglu, Ahmet, Di Stefano, Antonio, Mardinoglu, Adil
格式: Artigo
語言:Inglês
出版: MDPI 2021
主題:
Article
在線閱讀:https://ncbi.nlm.nih.gov/pmc/articles/PMC7835747/
https://ncbi.nlm.nih.gov/pubmed/33478054
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/biom11010126
標簽: 添加標簽
沒有標簽, 成為第一個標記此記錄!

相似書籍